Back
BlueLinx Holdings Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
47
BXC
BlueLinx Holdings
Last Price:
91.63
Seasonality Move:
11.35%
Buy
53
SRPT
Sarepta Therapeutics
Last Price:
158.06
Seasonality Move:
18.65%
Sell
47
BlueLinx Holdings (BXC)
is a Sell
Is BlueLinx Holdings a Buy, Sell or Hold?
- The current BlueLinx Holdings [BXC] share price is $91.25. The Score for BXC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- BXC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $156.91. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BXC Stock Price Chart
What is BlueLinx Holdings's stock price today?
-
The BlueLinx Holdings share price today is $91.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BXC is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $156.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.84 | Sell |
| Relative Strength Index (14 RSI): | 32.06 | Sell |
| Chaikin Money Flow: | 27742 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (95.43 - 102.09) | Sell |
| Bollinger Bands (100): | (101.23 - 123.23) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.17 | Buy |
| Relative Strength Index (14 RSI): | 68.43 | Buy |
| Chaikin Money Flow: | 1613298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.82 - 142.64) | Buy |
| Bollinger Bands (100): | (118.8 - 136.1) | Buy |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 95.6 | Sell |
| 20-day SMA: | 97.69 | Sell |
| 50-day SMA: | 102.62 | Sell |
| 200-day SMA: | 101.91 | Sell |
| 8-day EMA: | 94.77 | Sell |
| 20-day EMA: | 97.54 | Sell |
| 50-day EMA: | 102.76 | Sell |
| 200-day EMA: | 102.57 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 140.03 | Buy |
| 20-day SMA: | 129.22 | Buy |
| 50-day SMA: | 127.95 | Buy |
| 200-day SMA: | 115.45 | Buy |
| 8-day EMA: | 145.32 | Buy |
| 20-day EMA: | 134.79 | Buy |
| 50-day EMA: | 129.39 | Buy |
| 200-day EMA: | 120.67 | Buy |
BlueLinx Holdings Earnings Growth & BXC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.60 per share, an increase next quarter of $0.50 per share, a decrease this year of $2.69 per share, and an increase next year of $2.07 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
BlueLinx Holdings Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||